Description
Detailed description is being prepared by our clinical team.
Clinical Trials
NCT06120283
Phase 1
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
United States, Australia, Brazil, China, France, Japan, Malaysia, Moldova, New Z
NCT06257264
Phase 1
Active, not recruiting
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
United States, Australia, China, Israel, Moldova, New Zealand